ArticleCancers2022

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.

Rosaria De Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.